CT Cardiomegaly vs ElucidVivo A.3
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Tool A focuses on detecting cardiomegaly by automatically measuring the cardiothoracic ratio from CT chest images, providing quantitative data for heart size assessment. In contrast, Tool B specializes in the quantitative analysis of arterial plaque composition and stability from CT angiography to aid in atherosclerosis patient stratification. While both are FDA-cleared AI tools for cardiovascular imaging, they address distinct clinical challenges within the broader field of cardiology.
Choose CT Cardiomegaly if…
Choose CT Cardiomegaly if your primary need is rapid, automated detection and quantitative assessment of cardiomegaly from CT chest images. This tool is ideal for integrating into high-volume radiology workflows where a precise cardiothoracic ratio is required for initial screening or follow-up, providing quick PDF and JSON reports for straightforward data integration.
View CT Cardiomegaly →Choose ElucidVivo A.3 if…
Choose ElucidVivo A.3 if you require in-depth, quantitative analysis of arterial plaque composition and stability from CT angiography. This tool is best suited for stratifying atherosclerosis patients, optimizing treatment decisions, and visualizing detailed plaque characteristics, including LRNC and calcifications, to inform advanced cardiovascular care.
View ElucidVivo A.3 →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | CT Cardiomegaly | ElucidVivo A.3 |
|---|---|---|
| Pricing | Fixed-fee | Unknown |
| Deployment | Docker Container (Ubuntu 20.04), command-line software | Cloud and on-premise secure deployment. |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | CT Cardiomegaly | ElucidVivo A.3 |
|---|---|---|
| Name | CT Cardiomegaly | ElucidVivo A.3 |
| Company | Innolitics | Elucid Bioimaging |
| Description | Innolitics' CT Cardiomegaly is an FDA-cleared AI-powered command-line software that automatically measures cardiothoracic ratio from CT chest images, assisting physicians in cardiomegaly detection with quantitative data. | ElucidVivo A.3 by Elucid Bioimaging is an FDA-cleared AI-powered medical image analysis system that provides quantitative analysis of arterial plaque composition and stability from CT angiography. It assists physicians in atherosclerosis patient stratification and optimizes treatment decisions by offering detailed visualization and measurement of plaque characteristics validated against histology. |
| Key Features | Automatic cardiothoracic ratio measurement, Machine learning algorithms for segmentation, Segmentation of heart and thoracic cavity, Calculates linear and area-based cardiothoracic ratios, Outputs PDF and JSON reports, Command-line software tool, Non-adaptive machine learning using MONAI framework, Validated against manual measurements by board-certified radiologists | AI-powered quantitative analysis of arterial plaque, Objectively quantifies Lipid-Rich Necrotic Core (LRNC), matrix, and calcifications from CT images, Visualizes lesion-level plaque composition, Provides 3D visualization of highlighted vessels, Offers rotatable curved MPR vessel views and cross-sections, Aids in stratifying patients with atherosclerosis, Derives fractional flow reserve (FFRct) based on vessel wall vasodilative capacity, Validated on ground-truth histology |
| Categories | Cardiology AI, Radiology & Imaging AI | Cardiology AI, Radiology & Imaging AI |
| Specialties | Cardiology, Radiology | Cardiology, Radiology, Vascular Surgery |
Videos
Demos, reviews, and walkthroughs featuring CT Cardiomegaly and ElucidVivo A.3.
Loading videos…
Videos need JavaScript to load. Search YouTube directly →
Frequently Asked Questions
CT Cardiomegaly (Tool A) is designed to assist physicians in cardiomegaly detection by automatically measuring the cardiothoracic ratio from CT chest images. ElucidVivo A.3 (Tool B) provides quantitative analysis of arterial plaque composition and stability from CT angiography to aid in atherosclerosis patient stratification and optimize treatment decisions.
CT Cardiomegaly (Tool A) calculates linear and area-based cardiothoracic ratios. ElucidVivo A.3 (Tool B) objectively quantifies Lipid-Rich Necrotic Core (LRNC), matrix, and calcifications from CT images, and also derives fractional flow reserve (FFRct).
CT Cardiomegaly (Tool A) has been validated against manual measurements by board-certified radiologists. ElucidVivo A.3 (Tool B) offers detailed visualization and measurement of plaque characteristics validated against histology.
Both CT Cardiomegaly (Tool A) and ElucidVivo A.3 (Tool B) support Cardiology and Radiology. ElucidVivo A.3 (Tool B) additionally supports Vascular Surgery.